Category Archives: Medicare

The implications and future of TAVR

The story of the transcatheter aortic valve implant is well underway thanks to the fact that the Sapien valve, made by Edwards Lifesciences, is on the market, but there is more to this story. Following are three aspects of the…

FacebookTwitterGoogle+Share

Unhappiness of physicians is reflected in some startling numbers in career-recommendation survey

As I read through one particular healthcare-related news item recently, the lyrics to the old “If you’re happy and you know it” song just plain took over my subconscious thinking. You know the one I’m talking about: “If you’re happy…

FacebookTwitterGoogle+Share

Administration’s proposed cuts in U.S. spending on prevention/wellness programs are beyond puzzling

By JIM STOMMEN Medical Device Daily Contributing Writer The recent decision by the Obama administration to propose big-time funding cuts for medical prevention and wellness programs is, like many of the decisions that come out of Washington, puzzling to say…

FacebookTwitterGoogle+Share

TAVR: What it says about FDA and CMS

The story has been out for a while about transcatheter aortic valve replacement (TAVR), so maybe it’s time to project into the future. Before we head there, however, we should revisit the past. The pivotal event in this story is…

FacebookTwitterGoogle+Share

Ditching Medicare: Maybe crazy, but tougher than you think

There are many definitions for the word “crazy,” and here’s another. Crazy is when you want to get out of Medicare and save the government and the taxpayer money, but the government won’t let you. Recent reports indicate that a…

FacebookTwitterGoogle+Share

Medicare’s decision to cover weight-reduction efforts is a good move, but details still matter

By JIM STOMMEN Medical Device Daily Contributing Writer   Talk about eating from the public trough: The folks who run Medicare are putting their money where our collective mouths are. The nation’s largest health insurance plan reported awhile back that…

FacebookTwitterGoogle+Share

Buck for the bang: Premium med-tech pricing

By Adi Renbaum, senior VP for health policy and reimbursement, Neocure Group Cook Medical’s Zilver PTX is likely to become the first peripheral drug-eluting stent (DES) to be approved in the U.S., after an FDA advisory panel voted unanimously in…

FacebookTwitterGoogle+Share

A whole new world

Five years ago this month my byline began appearing on the pages of Medical Device Daily. When I first joined the MDD staff in October 2006 I knew very little about this industry. It was like moving to a new…

FacebookTwitterGoogle+Share

Parallel review: Still not a big deal?

  Well, FDA and the Centers for Medicare & Medicaid Services are at it again with parallel review, but this time they’ve tacitly acknowledged what everyone knew all along; that it would never be willingly adopted by more than a…

FacebookTwitterGoogle+Share

The Good, the Bad and the Ugly: Third-party coverage requests

As a member of the trade press, I get a kick out of how routinely some people in the mainstream media and the population at large routinely assume that device makers are driven by greed and that doctors are morally…

FacebookTwitterGoogle+Share

Marketo